Global Carrier Screening Market Trend and Development Strategy Analysis 2023-2029
Market Analysis and Insights: Global Carrier Screening Market
The global Carrier Screening market size in 2022 is 2100.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 14.10% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Carrier Screening market include GRAIL, LLC., Bio-Techne, ASURAGEN, INC., Laboratory Corporation of America Holdings, and Otogenetics. The share of the top 3 players in the Carrier Screening market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Carrier Screening market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Targeted Disease Carrier accounted for XX% of Carrier Screening market in 2022. Expanded Carrier share of XX%.
Pulmonary accounted for XX% of the Carrier Screening market in 2022. Genetic Disorders accounts for XX%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Carrier Screening market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Carrier Screening market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Carrier Screening market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Carrier Screening market.
Global Carrier Screening Scope and Market Size
Carrier Screening market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Carrier Screening market will be able to gain the upper hand as they use the report as a powerful resource.
The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Carrier Screening industry is considered in the report, covering the dynamic analysis of the development of the Carrier Screening industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Key Regions Covered in This Report Are
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some of the major players operating in the global market include:
GRAIL, LLC.
Bio-Techne
ASURAGEN, INC.
Laboratory Corporation of America Holdings
Otogenetics
Thermo Fisher Scientific Inc.
Myriad Genetics, Inc.
Natera, Inc.
Cepheid
F.Hoffmann-La Roche Ltd.
MedGenome
GeneTech
CENTOGENE N.V.
Autogenomics Inc.
Danaher Corporation
Eurofins Scientific
23Andme Inc.
Abbott Laboratories
Oxford Nanopore
Segment by Type
Targeted Disease Carrier
Expanded Carrier
Application list
Pulmonary
Genetic Disorders
Neurological
Hematological
Others
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
Table of Content
1 Carrier Screening Market Introduction and Overview
1.1 Carrier Screening Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Carrier Screening Industry Dynamic Analysis
1.5.1 Carrier Screening Market Trends Analysis
1.5.2 Carrier Screening Market Drivers Analysis
1.5.3 Carrier Screening Market Challenges Analysis
1.5.4 Carrier Screening Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Carrier Screening Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Carrier Screening Revenue and Share by Type
3 Global Carrier Screening Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Carrier Screening Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global Carrier Screening Market Size (2018-2023)
4.2 Carrier Screening Growth Insights by Regions
4.2.1 Carrier Screening Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Carrier Screening Revenue Market Size by Regions (2018-2023)
4.2.3 North America Carrier Screening Market Size (2018-2023)
4.2.4 Europe Carrier Screening Market Size (2018-2023)
4.2.5 Asia-Pacific Carrier Screening Market Size (2018-2023)
4.2.6 Latin America Carrier Screening Market Size (2018-2023)
4.2.7 Middle East & Africa Carrier Screening Market Size (2018-2023)
5 North America
5.1 North America Carrier Screening Revenue by Countries
5.1.1 North America Carrier Screening Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Carrier Screening Revenue by Countries
6.1.1 Asia Pacific Carrier Screening Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Carrier Screening Revenue by Countries
7.1.1 Europe Carrier Screening Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Carrier Screening Revenue by Countries
8.1.1 Latin America Carrier Screening Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Carrier Screening Revenue by Countries
9.1.1 Middle East & Africa Carrier Screening Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Carrier Screening Market Competition, by Players
10.1 Global Carrier Screening Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Carrier Screening Players Market Share in 2022
10.2.2 Top 6 Carrier Screening Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Carrier Screening Players Head Office, Business Provided
10.4 Carrier Screening Mergers & Acquisitions
10.5 Carrier Screening New Entrants and Expansion Plans
11 Players Profiles
11.1 GRAIL, LLC.
11.1.1 GRAIL, LLC. Company Profile
11.1.2 Carrier Screening Product Overview
11.1.3 GRAIL, LLC. Carrier Screening Market Performance (2018-2023)
11.1.4 GRAIL, LLC. Business Overview
11.1.5 Recent Developments and Plans
11.2 Bio-Techne
11.2.1 Bio-Techne Company Profile
11.2.2 Carrier Screening Product Overview
11.2.3 Bio-Techne Carrier Screening Market Performance (2018-2023)
11.2.4 Bio-Techne Business Overview
11.2.5 Recent Developments and Plans
11.3 ASURAGEN, INC.
11.3.1 ASURAGEN, INC. Company Profile
11.3.2 Carrier Screening Product Overview
11.3.3 ASURAGEN, INC. Carrier Screening Market Performance (2018-2023)
11.3.4 ASURAGEN, INC. Business Overview
11.3.5 Recent Developments and Plans
11.4 Laboratory Corporation of America Holdings
11.4.1 Laboratory Corporation of America Holdings Company Profile
11.4.2 Carrier Screening Product Overview
11.4.3 Laboratory Corporation of America Holdings Carrier Screening Market Performance (2018-2023)
11.4.4 Laboratory Corporation of America Holdings Business Overview
11.4.5 Recent Developments and Plans
11.5 Otogenetics
11.5.1 Otogenetics Company Profile
11.5.2 Carrier Screening Product Overview
11.5.3 Otogenetics Carrier Screening Market Performance (2018-2023)
11.5.4 Otogenetics Business Overview
11.5.5 Recent Developments and Plans
11.6 Thermo Fisher Scientific Inc.
11.6.1 Thermo Fisher Scientific Inc. Company Profile
11.6.2 Carrier Screening Product Overview
11.6.3 Thermo Fisher Scientific Inc. Carrier Screening Market Performance (2018-2023)
11.6.4 Thermo Fisher Scientific Inc. Business Overview
11.6.5 Recent Developments and Plans
11.7 Myriad Genetics, Inc.
11.7.1 Myriad Genetics, Inc. Company Profile
11.7.2 Carrier Screening Product Overview
11.7.3 Myriad Genetics, Inc. Carrier Screening Market Performance (2018-2023)
11.7.4 Myriad Genetics, Inc. Business Overview
11.7.5 Recent Developments and Plans
11.8 Natera, Inc.
11.8.1 Natera, Inc. Company Profile
11.8.2 Carrier Screening Product Overview
11.8.3 Natera, Inc. Carrier Screening Market Performance (2018-2023)
11.8.4 Natera, Inc. Business Overview
11.8.5 Recent Developments and Plans
11.9 Cepheid
11.9.1 Cepheid Company Profile
11.9.2 Carrier Screening Product Overview
11.9.3 Cepheid Carrier Screening Market Performance (2018-2023)
11.9.4 Cepheid Business Overview
11.9.5 Recent Developments and Plans
11.10 F.Hoffmann-La Roche Ltd.
11.10.1 F.Hoffmann-La Roche Ltd. Company Profile
11.10.2 Carrier Screening Product Overview
11.10.3 F.Hoffmann-La Roche Ltd. Carrier Screening Market Performance (2018-2023)
11.10.4 F.Hoffmann-La Roche Ltd. Business Overview
11.10.5 Recent Developments and Plans
11.11 MedGenome
11.11.1 MedGenome Company Profile
11.11.2 Carrier Screening Product Overview
11.11.3 MedGenome Carrier Screening Market Performance (2018-2023)
11.11.4 MedGenome Business Overview
11.11.5 Recent Developments and Plans
11.12 GeneTech
11.12.1 GeneTech Company Profile
11.12.2 Carrier Screening Product Overview
11.12.3 GeneTech Carrier Screening Market Performance (2018-2023)
11.12.4 GeneTech Business Overview
11.12.5 Recent Developments and Plans
11.13 CENTOGENE N.V.
11.13.1 CENTOGENE N.V. Company Profile
11.13.2 Carrier Screening Product Overview
11.13.3 CENTOGENE N.V. Carrier Screening Market Performance (2018-2023)
11.13.4 CENTOGENE N.V. Business Overview
11.13.5 Recent Developments and Plans
11.14 Autogenomics Inc.
11.14.1 Autogenomics Inc. Company Profile
11.14.2 Carrier Screening Product Overview
11.14.3 Autogenomics Inc. Carrier Screening Market Performance (2018-2023)
11.14.4 Autogenomics Inc. Business Overview
11.14.5 Recent Developments and Plans
11.15 Danaher Corporation
11.15.1 Danaher Corporation Company Profile
11.15.2 Carrier Screening Product Overview
11.15.3 Danaher Corporation Carrier Screening Market Performance (2018-2023)
11.15.4 Danaher Corporation Business Overview
11.15.5 Recent Developments and Plans
11.16 Eurofins Scientific
11.16.1 Eurofins Scientific Company Profile
11.16.2 Carrier Screening Product Overview
11.16.3 Eurofins Scientific Carrier Screening Market Performance (2018-2023)
11.16.4 Eurofins Scientific Business Overview
11.16.5 Recent Developments and Plans
11.17 23Andme Inc.
11.17.1 23Andme Inc. Company Profile
11.17.2 Carrier Screening Product Overview
11.17.3 23Andme Inc. Carrier Screening Market Performance (2018-2023)
11.17.4 23Andme Inc. Business Overview
11.17.5 Recent Developments and Plans
11.18 Abbott Laboratories
11.18.1 Abbott Laboratories Company Profile
11.18.2 Carrier Screening Product Overview
11.18.3 Abbott Laboratories Carrier Screening Market Performance (2018-2023)
11.18.4 Abbott Laboratories Business Overview
11.18.5 Recent Developments and Plans
11.19 Oxford Nanopore
11.19.1 Oxford Nanopore Company Profile
11.19.2 Carrier Screening Product Overview
11.19.3 Oxford Nanopore Carrier Screening Market Performance (2018-2023)
11.19.4 Oxford Nanopore Business Overview
11.19.5 Recent Developments and Plans
12 Global Carrier Screening Forecast Market Insights by Type
12.1 Global Carrier Screening Revenue Market Forecast by Type (2023-2029)
13 Global Carrier Screening Forecast Market Insights by Application
13.1 Carrier Screening Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global Carrier Screening Forecast Market Size (2023-2029)
14.2 Carrier Screening Growth Forecast Insights by Regions
14.2.1 Carrier Screening Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Carrier Screening Forecast Market Size (2023-2029)
14.2.3 Europe Carrier Screening Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Carrier Screening Forecast Market Size (2023-2029)
14.2.5 Latin America Carrier Screening Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Carrier Screening Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer
List of Tables and Figures
Figure Carrier Screening Picture
Table Product Definition of Carrier Screening
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Carrier Screening Market Size by Type (2018 VS 2023 VS 2029)
Table Global Carrier Screening Revenue by Type (2018-2023)
Table Global Carrier Screening Revenue and Share by Type (2018-2023)
Table Global Carrier Screening Market Size by Application (2018 VS 2023 VS 2029)
Table Global Carrier Screening Revenue by Application (2018-2023)
Table Global Carrier Screening Revenue Share by Application (2018-2023)
Figure Global Carrier Screening Revenue Market Size Growth (2018-2023)
Table Carrier Screening Market Size by Regions: 2018 VS 2023 VS 2029
Table Carrier Screening Revenue Market Size by Regions (2018-2023)
Table Carrier Screening Revenue and Share by Regions (2018-2023)
Figure North America Carrier Screening Market Size (2018-2023)
Figure Europe Carrier Screening Market Size (2018-2023)
Figure Asia-Pacific Carrier Screening Market Size (2018-2023)
Figure Latin America Carrier Screening Market Size (2018-2023)
Figure Middle East & Africa Carrier Screening Market Size (2018-2023)
Table North America Carrier Screening Revenue by Countries (2018-2023)
Table North America Carrier Screening Revenue and Share by Countries (2018-2023)
Table North America PEST Analysis
Figure United States Carrier Screening Revenue and Growth (2018-2023)
Figure Canada Carrier Screening Revenue and Growth (2018-2023)
Figure Canada Carrier Screening Sales and Growth (2018-2023)
Table Asia-Pacific Carrier Screening Revenue by Countries (2018-2023)
Table Asia-Pacific Carrier Screening Revenue and Share by Countries (2018-2023)
Table Asia-Pacific PEST Analysis
Figure China Carrier Screening Revenue and Growth (2018-2023)
Figure Japan Carrier Screening Revenue and Growth (2018-2023)
Figure Korea Carrier Screening Revenue and Growth (2018-2023)
Figure Southeast Asia Carrier Screening Revenue and Growth (2018-2023)
Figure India Carrier Screening Revenue and Growth (2018-2023)
Figure Australia Carrier Screening Revenue and Growth (2018-2023)
Table Europe Carrier Screening Revenue by Countries (2018-2023)
Table Europe Carrier Screening Revenue and Share by Countries (2018-2023)
Table Europe PEST Analysis
Figure Germany Carrier Screening Revenue and Growth (2018-2023)
Figure France Carrier Screening Revenue and Growth (2018-2023)
Figure UK Carrier Screening Revenue and Growth (2018-2023)
Figure Italy Carrier Screening Revenue and Growth (2018-2023)
Figure Russia Carrier Screening Revenue and Growth (2018-2023)
Figure Spain Carrier Screening Revenue and Growth (2018-2023)
Figure Nordic Carrier Screening Revenue and Growth (2018-2023)
Table Latin America Carrier Screening Revenue by Countries (2018-2023)
Table Latin America Carrier Screening Revenue and Share by Countries (2018-2023)
Table Latin America PEST Analysis
Figure Brazil Carrier Screening Revenue and Growth (2018-2023)
Figure Argentina Carrier Screening Revenue and Growth (2018-2023)
Figure Mexico Carrier Screening Revenue and Growth (2018-2023)
Table Middle East & Africa Carrier Screening Revenue by Countries (2018-2023)
Table Middle East & Africa Carrier Screening Revenue and Share by Countries (2018-2023)
Table Middle East & Africa PEST Analysis
Figure Egypt Carrier Screening Revenue and Growth (2018-2023)
Figure South Africa Carrier Screening Revenue and Growth (2018-2023)
Figure UAE Carrier Screening Revenue and Growth (2018-2023)
Figure Turkey Carrier Screening Revenue and Growth (2018-2023)
Figure Saudi Arabia Carrier Screening Revenue and Growth (2018-2023)
Table Global Carrier Screening Revenue by Players (2018-2023)
Table Global Carrier Screening Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Carrier Screening Players Market Concentration Ratio (CR5) (2018-2023)
Table Carrier Screening Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table GRAIL, LLC. Profile
Table Product Overview
Table GRAIL, LLC. Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure GRAIL, LLC. Revenue and Growth Rate
Figure GRAIL, LLC. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bio-Techne Profile
Table Product Overview
Table Bio-Techne Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Bio-Techne Revenue and Growth Rate
Figure Bio-Techne Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table ASURAGEN, INC. Profile
Table Product Overview
Table ASURAGEN, INC. Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure ASURAGEN, INC. Revenue and Growth Rate
Figure ASURAGEN, INC. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Laboratory Corporation of America Holdings Profile
Table Product Overview
Table Laboratory Corporation of America Holdings Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Laboratory Corporation of America Holdings Revenue and Growth Rate
Figure Laboratory Corporation of America Holdings Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Otogenetics Profile
Table Product Overview
Table Otogenetics Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Otogenetics Revenue and Growth Rate
Figure Otogenetics Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Thermo Fisher Scientific Inc. Profile
Table Product Overview
Table Thermo Fisher Scientific Inc. Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Thermo Fisher Scientific Inc. Revenue and Growth Rate
Figure Thermo Fisher Scientific Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Myriad Genetics, Inc. Profile
Table Product Overview
Table Myriad Genetics, Inc. Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Myriad Genetics, Inc. Revenue and Growth Rate
Figure Myriad Genetics, Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Natera, Inc. Profile
Table Product Overview
Table Natera, Inc. Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Natera, Inc. Revenue and Growth Rate
Figure Natera, Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Cepheid Profile
Table Product Overview
Table Cepheid Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Cepheid Revenue and Growth Rate
Figure Cepheid Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table F.Hoffmann-La Roche Ltd. Profile
Table Product Overview
Table F.Hoffmann-La Roche Ltd. Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure F.Hoffmann-La Roche Ltd. Revenue and Growth Rate
Figure F.Hoffmann-La Roche Ltd. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table MedGenome Profile
Table Product Overview
Table MedGenome Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure MedGenome Revenue and Growth Rate
Figure MedGenome Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table GeneTech Profile
Table Product Overview
Table GeneTech Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure GeneTech Revenue and Growth Rate
Figure GeneTech Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table CENTOGENE N.V. Profile
Table Product Overview
Table CENTOGENE N.V. Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure CENTOGENE N.V. Revenue and Growth Rate
Figure CENTOGENE N.V. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Autogenomics Inc. Profile
Table Product Overview
Table Autogenomics Inc. Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Autogenomics Inc. Revenue and Growth Rate
Figure Autogenomics Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Danaher Corporation Profile
Table Product Overview
Table Danaher Corporation Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Danaher Corporation Revenue and Growth Rate
Figure Danaher Corporation Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Eurofins Scientific Profile
Table Product Overview
Table Eurofins Scientific Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Eurofins Scientific Revenue and Growth Rate
Figure Eurofins Scientific Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table 23Andme Inc. Profile
Table Product Overview
Table 23Andme Inc. Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure 23Andme Inc. Revenue and Growth Rate
Figure 23Andme Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Abbott Laboratories Profile
Table Product Overview
Table Abbott Laboratories Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Abbott Laboratories Revenue and Growth Rate
Figure Abbott Laboratories Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Oxford Nanopore Profile
Table Product Overview
Table Oxford Nanopore Carrier Screening Revenue, Gross and Gross Margin (2018-2023)
Figure Oxford Nanopore Revenue and Growth Rate
Figure Oxford Nanopore Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Carrier Screening Revenue Forecast by Type (2023-2029)
Table Global Carrier Screening Revenue and Share Forecast by Type (2023-2029)
Table Global Carrier Screening Revenue by Application (2023-2029)
Table Global Carrier Screening Revenue and Share by Application (2023-2029)
Figure Global Carrier Screening Revenue Forecast Market Size (2023-2029)
Table Carrier Screening Revenue Forecast by Regions (2023-2029)
Table Carrier Screening Revenue and Share Forecast by Regions (2023-2029)
Figure North America Carrier Screening Revenue Forecast Market Size (2023-2029)
Figure Europe Carrier Screening Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Carrier Screening Revenue Forecast Market Size (2023-2029)
Figure Latin America Carrier Screening Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa Carrier Screening Revenue Forecast Market Size (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|